Status:

COMPLETED

Effect of a Nootropic on the Cognitive Performance in Young Adults

Lead Sponsor:

Universidad de Granada

Conditions:

Cognitive Change

Eligibility:

All Genders

18-35 years

Phase:

NA

Brief Summary

The main aim of this study is to determine the effect of a nootropic on cognitive performance (i.e., reaction time, inhibitory control, cognitive flexibility, working memory, neuro-psychological outco...

Detailed Description

Cognitive decline is a worrisome consequence of normal or pathologic ageing, having a high personal, eco- nomic and societal burden; also, it could herald the onset of dementia which is associated wit...

Eligibility Criteria

Inclusion

  • Healthy male or female
  • Ages 18-30 years
  • BMI: 18-30.0 kg/m2
  • Stable weight over the last 3 months (body weight changes\<3kg)
  • Participant must be capable and willing to provide consent, understand exclusion criteria, instructions and protocols.
  • To talk and to read Spanish fluently.

Exclusion

  • History of neurological disease or mental disease.
  • History of cardiovascular disease
  • Diabetes or hypertension
  • Pregnant, planning to become pregnant, or breastfeeding
  • Have been treated previously or during the study period with neurological drugs.
  • Have been treated previously or during the study period with prescription drugs: antihypertensive, lipid lowering, acid uric lowering, glucose lowering, beta blockers or any drug that under the investigator's judged could influence the results.
  • Allergy/intolerance to any ingredient of the nootropic.
  • High caffeine consumes (\>300mg/day, or \>3 coffees/day).
  • Any non-controlled medical condition which could influence results or could be worsened by the participation in the study.
  • Are deemed unsuitable by the investigator for any other reason, that prevent data collection.

Key Trial Info

Start Date :

April 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 15 2022

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04790188

Start Date

April 1 2021

End Date

May 15 2022

Last Update

May 18 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jonatan Ruiz Ruiz

Granada, Spain, 18011